BANNOCKBURN, Ill., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights (year-over-year comparisons unless otherwise noted) Net revenue of $1,465.4 million, up 8.8%Net income of $58.5 million, down 2.7%GAAP diluted earnings p ...

Group 1 - Option Care Health, Inc. will participate in the 46th Annual TD Cowen Healthcare Conference on March 3, 2026, with a fireside chat scheduled at 1:10pm ET [1] - The company is the largest independent provider of home and alternate site infusion services in the United States [2] - Option Care Health employs over 8,000 team members, including more than 5,000 clinicians, focusing on elevating care standards for patients with acute and chronic conditions across all 50 states [2] Group 2 - The company aims to reimagine the infusion care experience for patients, customers, and team members through its clinical leadership and national scale [2] - Additional information about the company can be found on its website [2] - Investor inquiries can be directed to Nicole Maggio, Senior Vice President, Corporate Controller [3]

Core Viewpoint - Option Care Health Inc. will release its fourth quarter and full year 2025 results on February 24, 2026, before market opening, followed by a conference call at 8:30 a.m. E.T. to discuss the results [1]. Group 1: Company Overview - Option Care Health is the largest independent provider of home and alternate site infusion services in the United States [3]. - The company employs over 8,000 team members, including more than 5,000 clinicians, dedicated to improving care standards for patients with acute and chronic conditions across all 50 states [3]. - Option Care Health aims to enhance the infusion care experience through its clinical leadership, expertise, and national scale [3]. Group 2: Conference Call Details - Participants can pre-register for the conference call through a provided link, and it will also be accessible via a live audio webcast on the company's investor relations website [2]. - A replay of the conference call will be available shortly after its completion and will remain accessible for approximately 90 days [2].

Core Insights - Option Care Health, Inc. announced preliminary unaudited financial results for Q4 and full year 2025, along with preliminary financial guidance for 2026 [1] Financial Results - Q4 2025 expected net revenue is projected between $1.46 billion and $1.47 billion, with GAAP net income between $59.1 million and $62.4 million, and adjusted diluted EPS between $0.46 and $0.49 [9] - Full year 2025 expected net revenue is projected between $5.645 billion and $5.655 billion, with GAAP net income between $208.2 million and $211.5 million, and adjusted diluted EPS between $1.72 and $1.76 [9] Financial Guidance - The company expects to provide further details regarding its full year 2026 financial guidance during the Q4 earnings call in February [3] Share Repurchase Program - The Board of Directors approved an increase in the share repurchase program authorization from $500 million to $1.0 billion, with no specified expiration date [4] - Approximately $95 million of shares were repurchased in Q4 2025, totaling approximately $307 million for the full year 2025 [5] Investor Engagement - Option Care Health will participate in the 44th Annual J.P. Morgan Healthcare Conference, with a presentation scheduled for January 13, 2026 [6]

Core Insights - Option Care Health is the largest independent provider of home and alternate site infusion services in the United States [2] Group 1: Company Participation - Option Care Health will participate in the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, with a presentation scheduled for 10:30am PT [1] Group 2: Company Overview - The company employs over 8,000 team members, including more than 5,000 clinicians, and operates across all 50 states [2] - Option Care Health aims to elevate standards of care for patients with acute and chronic conditions through its clinical leadership and expertise [2] - The company is focused on reimagining the infusion care experience for patients, customers, and team members [2]

Core Insights - Option Care Health is the leading home and alternate site infusion provider in the United States, operating over 90 full-service pharmacies and covering 96% of the population [3]. Group 1: Business Overview - The company infuses patients both in their homes and in over 700 alternate site suites, providing a full network of therapies for both acute and chronic conditions [3]. - Despite disruptions in 2024 due to events like hurricanes and supply chain shortages, the company has made significant progress and is optimistic about its performance [2]. Group 2: Market Position - Option Care Health's mission is to serve healthcare needs effectively, positioning itself as a critical player in the infusion services market [3].

BANK OF AMERICA LEVERAGED FINANCE CONFERENCE DECEMBER 2025 © 2025 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Disclaimers Forward-Looking Statements This presentation may contain "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "believe," "project," "estimate," "expect," "may," "should," "will" and similar references to fut ...

Core Insights - Option Care Health reported strong financial results for Q3 2025, with balanced growth across its service portfolio [2][6] - The company is well-positioned to navigate a dynamic regulatory environment and changing competitive landscape while focusing on patient care [2] Financial Performance - Net revenue reached $1,435.0 million, reflecting a year-over-year increase of 12.2% [6] - Gross profit was $272.9 million, up 6.3% from the previous year [6] - Net income decreased to $51.8 million, down 3.8% year-over-year [6] - GAAP diluted earnings per share increased to $0.32, up 3.2% [6] - Adjusted EBITDA was $119.5 million, an increase of 3.4% [6] - Adjusted diluted earnings per share rose to $0.45, up 9.8% [6] Updated Financial Guidance - For the full year 2025, the company expects net revenue between $5.60 billion and $5.65 billion [7] - Adjusted diluted earnings per share is projected to be between $1.68 and $1.72 [7] - Adjusted EBITDA is anticipated to be between $468 million and $473 million [7] - Cash flow from operations is expected to be at least $320 million [7] Operational Highlights - The company has over 8,000 team members, including more than 5,000 clinicians, providing infusion services across all 50 states [4] - Option Care Health is focused on elevating standards of care for patients with both acute and chronic conditions [4] Stock and Debt Management - The company repurchased $62.5 million of its stock during the quarter [6] - A term loan was expanded by $49.6 million, with a reduction in the interest rate [6]

Core Viewpoint - Option Care Health Inc. will release its third quarter results for the period ending September 30, 2025, on October 30, 2025, before market opening, followed by a conference call at 8:30 a.m. E.T. to discuss the results [1] Company Overview - Option Care Health is the largest independent provider of home and alternate site infusion services in the United States, employing over 8,000 team members, including more than 5,000 clinicians [3] - The company aims to elevate care standards for patients with acute and chronic conditions across all 50 states, leveraging its clinical leadership and national scale [3]

Core Insights - Option Care Health is the largest independent provider of home and alternate site infusion services in the United States [2] Company Overview - Option Care Health employs over 8,000 team members, including more than 5,000 clinicians, dedicated to improving care standards for patients with acute and chronic conditions across all 50 states [2] - The company aims to enhance the infusion care experience through clinical leadership, expertise, and national scale [2] Upcoming Events - Option Care Health will participate in the Deutsche Bank Healthcare Summit in New York City from September 10 to September 11, 2025 [3] - The company will also be present at the Jefferies Healthcare Services Conference in Nashville on September 30, 2025, featuring a fireside chat at 1:15 PM CT / 2:15 PM ET [3]